Conjupri Tablet
Product Images NDC 24075-0411

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Conjupri (NDC 24075-0411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cspc Ouyi Pharmaceutical Co. Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Conjupri Structure (Conjupri Image)

Chemical structure of levamlodipine, showing its molecular arrangement including a benzene ring with chlorine substitution, ester groups, an amine side chain, and an associated dicarboxylic acid molecule indicated as C4H4O4.*

FDA Label Image

Conjupri 5

Labels for Conjupri (levamlodipine) tablets, 5 mg strength, in bottles of 30, 90, and 500 tablets. Each label includes dosage form as oral tablets, the labeler CSPC Ouyi Pharmaceutical Co. Ltd, and storage instructions. The labels have a white background with purple accents and include barcodes and QR codes.*

FDA Label Image

Conjupri 25

Labels for Conjupri (levamlodipine) tablets, 2.5 mg oral tablets, in bottles of 30, 90, and 500 count. Each label features the strength 2.5 mg prominently in orange, barcode, NDC number starting with 24075-0411, and manufacturer CSPC Ouyi Pharmaceutical Co. Ltd, Shijiazhuang, Hebei, China. The labels advise storage instructions and note the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.